The Impact of Glucocorticoid Replacement after Surgery on Autoimmune Disease Risk
A recent retrospective matched cohort study revealed that patients with surgical remission of Cushing’s disease were more likely to develop autoimmune disease compared to those with surgically treated nonfunctioning pituitary adenomas (NFPAs). According to Lisa Nachtigall, MD, and colleagues from Massachusetts General Hospital in Boston, 10.4% of Cushing’s disease patients developed new-onset autoimmune disease at 3 years post-surgery, compared to 1.6% of NFPA patients (HR 7.80, 95% CI 2.88-21.10).
The study also found that patients with Cushing’s disease had a significantly higher prevalence of postoperative adrenal insufficiency (93.8% vs 16.5%) and lower postoperative cortisol levels (63.8 nmol/L vs 282.3 nmol/L) compared to NFPA patients. Nachtigall stressed the importance of evaluating patients for autoimmune and inflammatory disorders post-surgery, especially those exhibiting symptoms of steroid withdrawal like joint and muscle pain.
While the exact mechanism linking adrenal insufficiency and autoimmune disease remains unknown, it is speculated that low cortisol levels may trigger an inflammatory response. Further research is needed to explore this association and also consider similar phenomena in conditions with high cortisol levels, such as post-traumatic stress syndrome or severe acute illnesses.
Interestingly, the study found that Cushing’s patients who later developed autoimmune diseases had lower preoperative cortisol ratios and a higher family history of autoimmune diseases. Additionally, those who received slightly higher glucocorticoid replacement doses post-surgery were less likely to develop autoimmune diseases, suggesting a potential protective effect of glucocorticoids.
These findings highlight the importance of monitoring Cushing’s disease patients post-surgery for autoimmune diseases and optimizing glucocorticoid replacement therapy to reduce the risk of autoimmune complications. Further research is needed to better understand the complex interplay between glucocorticoids, adrenal insufficiency, and autoimmune diseases in postoperative Cushing’s patients.